Related Experiment Video
Updated: Jul 20, 2026
03:38
Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
Published on: October 6, 2022
Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification
Peter Porschewski1, Mira A-M Grättinger, Kerstin Klenzke
1QIAGEN GmbH, Hilden, Germany. peter.porschewski@qiagen.com
Journal of Biomolecular Screening
|September 1, 2006
Summary
Researchers developed novel aptamer-based assays using xMAP technology. These aptamer assays demonstrate high sensitivity and specificity for detecting biomarkers like alpha-thrombin in serum, advancing diagnostic and drug discovery applications.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Drug Discovery
Background:
- Traditional xMAP (Luminex) bead-based assays commonly immobilize antigens or antibodies.
- A need exists for adaptable and sensitive detection methods in diagnostics and drug screening.
Purpose of the Study:
- To develop and validate novel aptamer-based assays utilizing xMAP technology.
- To demonstrate the utility of immobilized aptamers for detecting biomarkers and screening small molecules.
Main Methods:
- Direct immobilization of synthetic aptamers onto xMAP beads.
- Development of direct detection assays for human alpha-thrombin in serum.
- Adaptation of xMAP technology to competitive screening formats using aptamer/protein complexes.
Main Results:
- Demonstrated robustness, specificity, and sensitivity of aptamer-based xMAP assays.
- Successfully detected human alpha-thrombin in serum samples.
- Validated competitive screening formats for identifying small-molecule drug candidates.
Conclusions:
- Aptamer-based xMAP assays are highly suitable for diagnostic applications and drug screening.
- Aptamers can serve as effective competitive binding probes for identifying small-molecule hits.
- The described methods are broadly transferable due to the ease of aptamer generation for various protein targets.
